In this study, the researchers want to understand how effective a drug called dexmedetomidine is in keeping the patients vital signs, such as blood pressure and heart rate, within a normal range during a medical procedure called modified electroconvulsive therapy (m-ECT).
Phase 2
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/05/067681
- Lead Sponsor
- Pt B D Sharma post graduate institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
belonging to American Society of Anaesthesiologists (ASA) physical status of I-II, who are
diagnosed with mood disorder and undergoing modified ECT
Exclusion Criteria
Following patients will be excluded from study
1)Refusal to consent by relatives
2) History of underlying renal, hepatic, cardiac and pulmonary diseases
3)History of head trauma
4) Patients who do not have seizures after receiving m – ECT.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on hemodynamic responses and post ictal agitationTimepoint: 15 min before ECT and upto 20 min after ECT
- Secondary Outcome Measures
Name Time Method 1) Motor seizure duration (in seconds) <br/ ><br>2) Time to spontaneous breathing (in seconds) <br/ ><br>3) Responding time to verbal commands (in minutes)Timepoint: 1)SBP,SBP,MAP,HR,RPP at 1 min, 3 min,5 min,10 min and 20 min. <br/ ><br>2)Motor seizure duration <br/ ><br>3) Emergence agitation score at 30min <br/ ><br>